Daclizumab for the treatment of adults with relapsing forms of multiple sclerosis

Osherov, M; Milo, R

Milo, R (reprint author), Barzilai Govt Hosp, Dept Neurol, 2 Hahistadrut St, IL-7830604 Ashqelon, Israel.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017; 10 (10): 1037

Abstract

Introduction: The goal of the article is to review the mechanism of action and the use of daclizumab, a humanized monoclonal antibody (mAb) against th......

Full Text Link